Skip to content
PubMed This is a summary of 4 peer-reviewed journal articles Updated
Neurology

Recognizing Symptoms and Warning Signs

At a Glance

DPM3-CDG can cause muscle weakness around the hips and shoulders and may also affect development, seizures, or heart function. Regular heart checks matter because cardiomyopathy can be silent; severe breathing trouble, fainting, chest pain, or blue skin require emergency care.

Symptoms of DPM3-CDG vary significantly from one person to another. Because it is an ultra-rare condition, doctors are still learning about the full spectrum of how it affects the body based on a very small number of published cases. While some people may only have muscle-related symptoms, others may experience challenges with brain development and heart health [1][2].

Muscle and Motor Symptoms

The most common feature of DPM3-CDG is muscle weakness, often classified as a form of limb-girdle muscular dystrophy [2]. This type of weakness primarily affects the “proximal” muscles—the large muscles closest to the center of the body, such as the hips, shoulders, and upper arms [2].

  • Timing: Weakness can begin at different ages. In some people, it starts in early childhood, while in others, it may not be noticeable until adulthood [2].
  • Severity: The muscle disease can range in severity. You may notice difficulty running, climbing stairs, or rising from a seated position [2][3]. The rate of progression is highly individualized.
  • Blood Markers: Many patients have elevated levels of creatine kinase (CK), an enzyme that leaks into the blood when muscle cells are fragile or damaged [3]. While CK is a marker of muscle injury, it does not directly measure strength or perfectly track progression.

Neurodevelopmental Symptoms

For some patients, the DPM3 gene change also affects how the brain develops and functions. This is sometimes referred to as a “muscle-plus-neurologic” presentation [1]. These symptoms can include:

  • Developmental Delay and Intellectual Disability: This ranges from mild to severe. It may affect how a person learns, speaks, or moves [1].
  • Microcephaly: A condition where the head size is smaller than expected for the person’s age and sex [1].
  • Seizures: Some patients develop seizures, which are abnormal bursts of electrical activity in the brain [1].
  • Brain Structure Changes: MRI scans may show white-matter abnormalities, which are changes in the tissue that helps different parts of the brain communicate [1]. Note that MRI and EEG scans are not routinely required for everyone; they are guided by developmental concerns or suspected seizures.

Heart Involvement: Dilated Cardiomyopathy

The heart is also a muscle, and in DPM3-CDG, it can become weakened over time. The specific concern is dilated cardiomyopathy (DCM)—a condition where the heart’s main pumping chamber becomes stretched out and thin, making it harder to pump blood to the rest of the body [2].

Current reports suggest that this heart weakening can emerge at different ages, though often in adolescence or adulthood [2]. Because this can happen silently, a baseline assessment and individualized routine heart check-ups (including an echocardiogram and ECG) are essential for all patients [4].

Emergency Red Flags: When to Seek Immediate Help

While routine symptoms, like steady muscle weakness, are managed by your care team during scheduled visits, certain cardiac and respiratory issues can become emergencies. Seek emergency medical evaluation immediately (call local emergency services) if you experience:

  • Sudden or Severe Breathlessness: Difficulty breathing at rest, inability to clear secretions, or a sharp, unexplained decrease in the ability to exercise or walk [2].
  • Prolonged Fainting (Syncope): Loss of consciousness or feeling like you are about to pass out, especially during physical activity.
  • Severe Chest Pain: Any pressure, squeezing, or pain in the chest area.
  • Bluish Skin (Cyanosis): A blue or gray tint to the lips, fingernails, or skin, indicating low oxygen levels.

Contact your clinician promptly for a same-day or urgent assessment for new palpitations (feeling like the heart is racing or skipping beats), new unexplained swelling (edema) in the ankles or legs, or excessive daytime sleepiness.

Common questions in this guide

What symptoms are most common in DPM3-CDG?
Muscle weakness is the most common feature and often affects the hips, shoulders, and upper arms. It may cause difficulty running, climbing stairs, or standing from a chair, and some people also have developmental delay, seizures, or heart problems. The age of onset and severity vary widely.
Can DPM3-CDG affect the heart even without symptoms?
Yes. DPM3-CDG can cause dilated cardiomyopathy, in which the heart’s main pumping chamber becomes stretched and weaker, and this may develop silently, often in adolescence or adulthood. A baseline echocardiogram and ECG, followed by a schedule tailored by the care team, can help monitor heart function.
Which warning signs require emergency care in DPM3-CDG?
Seek emergency help for severe or sudden breathing difficulty, trouble clearing secretions, a sharp unexplained decline in walking or exercise ability, prolonged fainting, severe chest pain, or blue or gray skin. New palpitations, meaning a racing or skipping heartbeat, unexplained leg swelling, or excessive daytime sleepiness should prompt same-day or urgent contact with a clinician.
Can DPM3-CDG cause developmental delays or seizures?
Some people with DPM3-CDG have developmental delay, intellectual disability, smaller-than-expected head size, or seizures, while others mainly have muscle symptoms. A brain MRI or an EEG, which records brain-wave activity, is generally guided by developmental concerns or suspected seizures rather than being required routinely for everyone.
What does a high CK level mean in DPM3-CDG?
Creatine kinase, or CK, is an enzyme that can rise when muscle cells are fragile or damaged. A high CK level is a marker of muscle injury, but it does not directly measure strength or reliably show how quickly the condition is progressing; testing frequency should be individualized.
How can muscle weakness from DPM3-CDG be managed safely?
A physical therapist or other member of the care team can help tailor activity, stretching, and mobility strategies to the person’s strength and limitations. Ask the treating team which exercises are safe, especially if weakness or fatigue is changing.
Can a DPM3 gene variant predict exactly how symptoms will develop?
Not reliably. DPM3-CDG is ultra-rare, and the small number of published cases show a wide range of muscle, neurologic, and heart findings. A clinician with genetics expertise can interpret the specific variant alongside the person’s symptoms and test results.

Get notified when new evidence is published on DPM3-CDG.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (4)
  1. 1

    A recurrent homozygous missense DPM3 variant leads to muscle and brain disease.

    Nagy S, Lau T, Alavi S, et al.

    Clinical genetics 2022; (102(6)):530-536 doi:10.1111/cge.14208.

    PMID: 35932216
  2. 2

    Dilated cardiomyopathy and limb-girdle muscular dystrophy-dystroglycanopathy due to novel pathogenic variants in the DPM3 gene.

    Svahn J, Laforêt P, Vial C, et al.

    Neuromuscular disorders : NMD 2019; (29(7)):497-502 doi:10.1016/j.nmd.2019.05.004.

    PMID: 31266720
  3. 3

    Toward understanding tissue-specific symptoms in dolichol-phosphate-mannose synthesis disorders; insight from DPM3-CDG.

    van Tol W, Michelakakis H, Georgiadou E, et al.

    Journal of inherited metabolic disease 2019; (42(5)):984-992 doi:10.1002/jimd.12095.

    PMID: 30931530
  4. 4

    Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.

    Zemet R, Hope KD, Edmondson AC, et al.

    Molecular genetics and metabolism 2024; (142(4)):108513 doi:10.1016/j.ymgme.2024.108513.

    PMID: 38917675

This page is for informational purposes only and does not constitute medical advice. Discuss DPM3-CDG symptoms, heart monitoring, and emergency warning signs with your clinician, and seek urgent help for severe symptoms.